Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

NASDAQLPCN
Price & Volume
Recent Price$7.56
52 Week High$11.79
52 Week Low$2.31
Average Volume (30 days)68.22K
Beta1.12
Share Related Items
Market Cap$40.43M
Shares Outstanding5.35M
Float5.02M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-32.3%
Financial Strength
Quick Ratio (MRQ)--
Current Ratio (MRQ)--
LT Debt/Capital (MRQ)0%
Total Debt/Equity (MRQ)--
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)9.18
Price/Book (MRQ)1.72
Price/Cash Flow (TTM)4.30
Per Share Data
Earnings (TTM)($1.97)
Sales (TTM)($0.53)
Book Value (MRQ)$4.49
Cash Flow (TTM)--
Cash (MRQ)$4.63
Management Effectiveness
Return on Equity (TTM)--
Return on Assets (TTM)--
Return on Investment (TTM)--
Profitability
Gross Margin (TTM)--
EBIT Margin (TTM)--
Profit Margin (TTM)--